Long-term low-dose warfarin use is effective in the prevention of recurrent venous thromboembolism: yes.
Ridker
P M
PM
Center for Cardiovascular Disease Prevention, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA. pridker@partners.org
D002986:Clinical Trials as Topic; D006470:Hemorrhage / Q000139:chemically induced; D006801:Humans; D018570:Risk Assessment; D055502:Secondary Prevention; D013923:Thromboembolism / Q000188:drug therapy* / Q000517:prevention & control; D013995:Time; D020246:Venous Thrombosis / Q000188:drug therapy* / Q000517:prevention & control; D014859:Warfarin / Q000008:administration & dosage* / Q000009:adverse effects / Q000627:therapeutic use
D014859:Warfarin